Share “News Summary: Mylan to buy Agila for $1.6...”

News Summary: Mylan to buy Agila for $1.6 billion

Published on NewsOK Modified: February 27, 2013 at 5:53 pm •  Published: February 27, 2013
Advertisement

THE DEAL: Mylan Inc., one of the world's largest maker of generic drugs, is buying Agila Specialties of India for $1.6 billion to expand its offerings of injectable drugs and boost its sales in emerging markets.

THE RESULTS: The Pittsburgh company also reported a 25 percent increase in fourth-quarter net income on double-digit revenue growth. Mylan earned 39 cents per share, or 65 cents per share excluding items, a penny ahead of expectations.

THE FORECAST: Mylan forecast adjusted income of $2.75 to $2.95 per share and revenue of $7 billion to $7.4 billion for 2013. Analysts expect earnings per share of $2.81 on revenue of $7.14 billion.


AROUND THE WEB

  1. 1
    2 Maryland law enforcement dogs die of heat exhaustion inside car
  2. 2
    Blumenthal: John Boehner is 'alcoholic,' 'lazy,' 'banal' | Washington Examiner
  3. 3
    Emails: Hillary kept close ties to Clinton Foundation while at State | Washington Examiner
  4. 4
    Radioactive chemical spill occurred last fall at University of Tulsa, officials announce
  5. 5
    Priceline.com reveals top Labor Day, Fall destinations for 2015
+ show more

FEATURED JOBS



× Trending business Article